<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03240198</url>
  </required_header>
  <id_info>
    <org_study_id>MB2PROF</org_study_id>
    <nct_id>NCT03240198</nct_id>
  </id_info>
  <brief_title>Biological Markers for Professional COPD</brief_title>
  <acronym>MB2PROF</acronym>
  <official_title>Marqueurs Biologiques Des Bronchopneumopathies Chroniques Obstructives Professionnelles</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Intercommunal Creteil</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Centre Hospitalier Universitaire de Besancon</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University Hospital, Bordeaux</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University Hospital, Caen</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University Hospital, Lille</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Centre Hospitalier Le Havre</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Henri Mondor University Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Centre Hospitalier Intercommunal Creteil</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Chronic obstructive pulmonary disease (COPD) is a frequent disease, mainly linked to tobacco
      smoking leading to chronic respiratory failure. It is characterized by an inflammatory spate
      with modification of protease-antiprotease and oxidant-antioxydant balances. Local
      modifications are associated with systemic changes. Many occupational factors have been
      associated with an excess of COPD in epidemiological studies, however without identification
      of any specific clinical or biological phenotype.

      Pathophysiological pathways involved in COPD might be different according to etiologic
      agents. Therefore, it is important to focus research on blood biomarkers associated with some
      well-characterized occupational COPD.

      The objectives of MB2PROF project are:

        1. To build the first multicentric cohort of cases of occupational COPD, with collection of
           plasma and DNA samples,

        2. To study the evolution of clinical and lung function parameters of occupational COPD in
           comparison with non occupational COPD during a follow-up study,

        3. To identify biological phenotypes of COPD associated to a given etiological agent.

      The methodology includes:

        1. The constitution of a cohort with a clinical and biological follow-up during 5 years.
           Subjects will be recruited in 7 occupational diseases departments, with the
           collaboration of Pneumology departments.

           Four groups of males subjects will be recruited (G1 : occupational COPD (6 groups of 60
           subjects, corresponding to 6 groups of occupational agents) ; G2 : non occupational COPD
           (n = 60) ; G3 : subjects with similar occupational exposure to G1 subjects but without
           COPD (6 groups of 60 subjects) ; G4 : subjects free of occupational exposure and of COPD
           (n = 60)), paired on tobacco-smoking and age. For each subject, information on clinical
           data, lung function parameters, occupation history and blood samples will be collected.

        2. The identification of biomarkers, using proteomic and genomic approaches according to
           subgroups (with different etiologies) of occupational COPD,

        3. The study of molecular pathways identified in these subgroups, with in vitro and in vivo
           studies The MB2PROF project is an original and ambitious multidisciplinary and
           translational project. The constitution of well-characterized COPD cases cohort should
           allow the identification of biomarkers and molecular pathways associated with some
           subgroup of subjects, and improve the knowledge of mechanisms involved.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>January 2010</start_date>
  <completion_date type="Anticipated">January 2021</completion_date>
  <primary_completion_date type="Actual">January 2016</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>C Protein Reactive</measure>
    <time_frame>at year 1</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>blood inflammatory markers</measure>
    <time_frame>at year 1</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>C Protein Reactive</measure>
    <time_frame>every year during 5 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>blood inflammatory markers</measure>
    <time_frame>every year during 5 years</time_frame>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">400</enrollment>
  <condition>Copd</condition>
  <arm_group>
    <arm_group_label>COPD</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Controls</arm_group_label>
  </arm_group>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Blood samples
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        COPD and healthy subjects exposed to tobacco smoking and/or to occupational dust
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  COPD

        Exclusion Criteria:

          -  Other obstructive disease
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>CHI Créteil</name>
      <address>
        <city>Créteil</city>
        <zip>94000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Pascal Andujar, MD PhD</last_name>
      <phone>33 1 57 02 20 95</phone>
      <email>pascal.andujar@chicreteil.fr</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>August 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 23, 2016</study_first_submitted>
  <study_first_submitted_qc>August 2, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">August 7, 2017</study_first_posted>
  <last_update_submitted>August 29, 2017</last_update_submitted>
  <last_update_submitted_qc>August 29, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">August 30, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Centre Hospitalier Intercommunal Creteil</investigator_affiliation>
    <investigator_full_name>Pascal ANDUJAR</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>occupational</keyword>
  <keyword>cohort</keyword>
  <keyword>biomarkers</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

